ResearcherKanagawa Cancer CenterNo recent work listed
Erica Yada
Matched on OpenAlex author ID A5002983982. Sources: OpenAlex.
Their work
- Papers
- 5 (first author 3, last author 0)
- Trials
- 0
- Grants
- 0
- Labs led
- 0
- Collaborators
- 13
2018: 1 paper · 2019: none · 2020: 2 papers · 2021: 2 papers
Papers 5
- Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer. Co-author DOI 10.3390/biomedicines9101396↗
- High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor prognosis in pancreatic cancer. First author DOI 10.3892/ijo.2020.5147↗
- High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. First author DOI 10.1371/journal.pone.0226707↗
- High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in pancreatic cancer. First author DOI 10.3892/or.2020.7610↗
- Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreatic cancer. Co-author DOI 10.18632/oncotarget.25837↗
Closest collaborators
The 13 strongest of 13 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.
- Satoshi Wada · 5 shared papers, 2018–2021 · strength 0.47
- Paper Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer. DOI 10.3390/biomedicines9101396↗
- Paper High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor pr… DOI 10.3892/ijo.2020.5147↗
- Paper Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreat… DOI 10.18632/oncotarget.25837↗
- Tetsuro Sasada · 5 shared papers, 2018–2021 · strength 0.47
- Paper Possible Role of Cytochrome P450 1B1 in the Mechanism of Gemcitabine Resistance in Pancreatic Cancer. DOI 10.3390/biomedicines9101396↗
- Paper High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor pr… DOI 10.3892/ijo.2020.5147↗
- Paper Identification of a novel HLA-A24-restricted cytotoxic T lymphocyte epitope peptide derived from mesothelin in pancreat… DOI 10.18632/oncotarget.25837↗
- Yutaro Kubota · 3 shared papers, 2020–2021 · strength 0.25
- Paper High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor pr… DOI 10.3892/ijo.2020.5147↗
- Paper High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in p… DOI 10.3892/or.2020.7610↗
- Paper High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. DOI 10.1371/journal.pone.0226707↗
- Ryotaro Ohkuma · 3 shared papers, 2020–2021 · strength 0.25
- Paper High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor pr… DOI 10.3892/ijo.2020.5147↗
- Paper High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in p… DOI 10.3892/or.2020.7610↗
- Paper High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. DOI 10.1371/journal.pone.0226707↗
- Tomoko Norose · 3 shared papers, 2020–2021 · strength 0.25
- Paper High levels of human epididymis protein 4 mRNA and protein expression are associated with chemoresistance and a poor pr… DOI 10.3892/ijo.2020.5147↗
- Paper High expression levels of polymeric immunoglobulin receptor are correlated with chemoresistance and poor prognosis in p… DOI 10.3892/or.2020.7610↗
- Paper High expression of olfactomedin-4 is correlated with chemoresistance and poor prognosis in pancreatic cancer. DOI 10.1371/journal.pone.0226707↗
- Yohei Miyagi · 1 shared paper, 2021 · strength 0.14
- Hiroki Yamaue · 1 shared paper, 2018 · strength 0.08
- Hiroyuki Kuwano · 1 shared paper, 2018 · strength 0.08
- Seiko Hirono · 1 shared paper, 2018 · strength 0.08
- Mariko Tsukagoshi · 1 shared paper, 2018 · strength 0.08
- Ken Shirabe · 1 shared paper, 2018 · strength 0.08
- Koji Tamada · 1 shared paper, 2020 · strength 0.08
- Takehiko Yokobori · 1 shared paper, 2020 · strength 0.08
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.